Jon is probably right in terms of the actual clinical trial. However, in this market, if you want a hefty premium in a potential take over scenario prior to phase 3 read out, a breakthrough designation is a must have
NEU Price at posting:
$14.05 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)